The proceeds will help accelerate adoption of the Ossiofiber intelligent bone regeneration technology, CEO Brian Verrier said in an Oct. 17 news release. Money will also support new product development, sales force expansion, patient outreach and medical education.
Ossiofiber is designed for rapid bone ingrowth, regeneration and replacement. It has been implanted in more than 10,000 cases.
MVM Partners, a Boston-based growth equity firm, led financing.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
